Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
- PMID: 20581818
- PMCID: PMC3072750
- DOI: 10.1038/nn.2583
Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Abstract
Alzheimer's disease is the most frequent neurodegenerative disorder and the most common cause of dementia in the elderly. Diverse lines of evidence suggest that amyloid-beta (Abeta) peptides have a causal role in its pathogenesis, but the underlying mechanisms remain uncertain. Here we discuss recent evidence that Abeta may be part of a mechanism controlling synaptic activity, acting as a positive regulator presynaptically and a negative regulator postsynaptically. The pathological accumulation of oligomeric Abeta assemblies depresses excitatory transmission at the synaptic level, but also triggers aberrant patterns of neuronal circuit activity and epileptiform discharges at the network level. Abeta-induced dysfunction of inhibitory interneurons likely increases synchrony among excitatory principal cells and contributes to the destabilization of neuronal networks. Strategies that block these Abeta effects may prevent cognitive decline in Alzheimer's disease. Potential obstacles and next steps toward this goal are discussed.
Figures
Similar articles
-
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.Mol Neurodegener. 2014 Nov 14;9:48. doi: 10.1186/1750-1326-9-48. Mol Neurodegener. 2014. PMID: 25394486 Free PMC article. Review.
-
Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.Rev Neurosci. 2009;20(1):1-12. doi: 10.1515/revneuro.2009.20.1.1. Rev Neurosci. 2009. PMID: 19526730 Review.
-
Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.Curr Drug Targets CNS Neurol Disord. 2005 Aug;4(4):383-403. doi: 10.2174/1568007054546117. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 16101556 Review.
-
Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer's disease.J Neurochem. 2012 Jan;120 Suppl 1(Suppl 1):140-148. doi: 10.1111/j.1471-4159.2011.07506.x. Epub 2011 Nov 28. J Neurochem. 2012. PMID: 22122128 Free PMC article. Review.
-
Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.Neurochem Res. 2003 Nov;28(11):1743-56. doi: 10.1023/a:1026073324672. Neurochem Res. 2003. PMID: 14584828 Review.
Cited by
-
Spatial learning and memory impairments are associated with increased neuronal activity in 5XFAD mouse as measured by manganese-enhanced magnetic resonance imaging.Oncotarget. 2016 Sep 6;7(36):57556-57570. doi: 10.18632/oncotarget.11353. Oncotarget. 2016. PMID: 27542275 Free PMC article.
-
Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy.Int J Alzheimers Dis. 2012;2012:630182. doi: 10.1155/2012/630182. Epub 2012 Mar 8. Int J Alzheimers Dis. 2012. PMID: 22482074 Free PMC article.
-
Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.J Neural Transm (Vienna). 2015 Oct;122(10):1475-97. doi: 10.1007/s00702-015-1404-6. Epub 2015 May 6. J Neural Transm (Vienna). 2015. PMID: 25944089 Review.
-
Effects of small interfering RNA targeting sphingosine kinase-1 gene on the animal model of Alzheimer's disease.J Huazhong Univ Sci Technolog Med Sci. 2013 Jun;33(3):427-432. doi: 10.1007/s11596-013-1136-5. Epub 2013 Jun 17. J Huazhong Univ Sci Technolog Med Sci. 2013. PMID: 23771672
-
Amyloid-β: a potential link between epilepsy and cognitive decline.Nat Rev Neurol. 2021 Aug;17(8):469-485. doi: 10.1038/s41582-021-00505-9. Epub 2021 Jun 11. Nat Rev Neurol. 2021. PMID: 34117482 Review.
References
-
- Chapman PF, et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 1999;2:271–276. - PubMed
-
- Walsh DM, et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416:535–539. - PubMed
-
- Kamenetz F, et al. APP processing and synaptic function. Neuron. 2003;37:925–937. - PubMed
-
- Cirrito JR, et al. Synaptic activity regulates interstitial fluid amyloid-β levels in vivo. Neuron. 2005;48:913–922. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical